Neonc Technologies Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 8

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 3

Neonc Technologies General Information

Description

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

Contact Information

Website
www.neonc.com
Formerly Known As
Neonc Technologies California, NAS-ONC
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Two Dole Drive
  • Westlake Village, CA 91362
  • United States
+1 (310)
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Two Dole Drive
  • Westlake Village, CA 91362
  • United States
+1 (310)

Neonc Technologies Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neonc Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. IPO 29-Oct-2024 Announced Generating Revenue/Not Profitable
10. Later Stage VC 26-Jun-2024 Completed Clinical Trials - Phase 2
9. IPO 12-Jun-2024 Cancelled Clinical Trials - Phase 2
8. Later Stage VC 08-Feb-2023 Completed Clinical Trials - Phase 2
7. Later Stage VC 24-Feb-2022 Completed Clinical Trials - Phase 2
6. Grant 01-Jan-2018 Completed Clinical Trials - Phase 2
5. Later Stage VC 08-Jun-2017 Cancelled Clinical Trials - Phase 2
4. Grant 01-Jan-2016 Completed Clinical Trials - Phase 2
3. Later Stage VC 22-Feb-2013 $175K $344K Completed Clinical Trials - Phase 2
2. Early Stage VC 27-Dec-2010 $78.5K $169K Completed Clinical Trials - Phase 2
To view Neonc Technologies’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Neonc Technologies Patents

  • 54

    Total Documents Applications and Grants

  • Total Patents Families

  • 24

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Neonc Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240216293-A1 Use of perillyl alcohol to enhance levo-dopa delivery Pending 28-Apr-2021
EP-4243794-A1 Treatment of recurrent gioblastoma with perillyl alcohol Pending 12-Nov-2020
EP-4228648-A1 Combination of poh and remdesivir for treatment of cns infections Pending 16-Oct-2020
EP-4228648-A4 Combination of poh and remdesivir for treatment of cns infections Pending 16-Oct-2020
JP-2023145654-A Methods of permeabilizing blood brain barrier Pending 08-Feb-2018 A61K31/045
To view Neonc Technologies’s complete patent history, request access »

Neonc Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neonc Technologies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eminent Venture Capital Venture Capital Minority
Lin Family Office Family Office Minority
U.S. Department of Health and Human Services Government
To view Neonc Technologies’s complete investors history, request access »

Ready to get started?

Request a free trial

Neonc Technologies FAQs

  • When was Neonc Technologies founded?

    Neonc Technologies was founded in 2008.

  • Where is Neonc Technologies headquartered?

    Neonc Technologies is headquartered in Westlake Village, CA.

  • What is the size of Neonc Technologies?

    Neonc Technologies has 8 total employees.

  • What industry is Neonc Technologies in?

    Neonc Technologies’s primary industry is Drug Discovery.

  • Is Neonc Technologies a private or public company?

    Neonc Technologies is a Private company.

  • What is Neonc Technologies’s current revenue?

    The current revenue for Neonc Technologies is .

  • How much funding has Neonc Technologies raised over time?

    Neonc Technologies has raised $28.9M.

  • Who are Neonc Technologies’s investors?

    Eminent Venture Capital, Lin Family Office, and U.S. Department of Health and Human Services have invested in Neonc Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »